Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy
- 4 November 2004
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 12 (2) , 187-193
- https://doi.org/10.1038/sj.gt.3302404
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Targeting ofAdenovirus via Genetic Modification of the Viral Capsid Combined with aProteinBridgeJournal of Virology, 2003
- Gene Expression Patterns in Ovarian CarcinomasMolecular Biology of the Cell, 2003
- Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinomaGene Therapy, 2003
- Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroidsCancer Gene Therapy, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- An Immunomagnetic-Based Method for the Purification of Ovarian Cancer Cells from Patient-Derived AscitesGynecologic Oncology, 2001
- Structure of the Mesothelin/MPF Gene and Characterization of Its PromoterMolecular Cell Biology Research Communications, 2000
- A Novel Tumor-Specific Replication-Restricted Adenoviral Vector for Gene Therapy of Hepatocellular CarcinomaHuman Gene Therapy, 1999
- Strategies for achieving multiple layers of selectivity in gene therapyMolecular Medicine Today, 1998
- Molecular cloning and expression of a cDNA encoding a protein detected by the ki antibody from an ovarian carcinoma (OVCAR‐3) cell lineInternational Journal of Cancer, 1994